252 related articles for article (PubMed ID: 10428479)
1. Cathepsin L is capable of truncating cystatin C of 11 N-terminal amino acids.
Popovic T; Cimerman N; Dolenc I; Ritonja A; Brzin J
FEBS Lett; 1999 Jul; 455(1-2):92-6. PubMed ID: 10428479
[TBL] [Abstract][Full Text] [Related]
2. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases.
Mason RW; Sol-Church K; Abrahamson M
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):833-8. PubMed ID: 9480898
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for different inhibitory specificities of human cystatins C and D.
Hall A; Ekiel I; Mason RW; Kasprzykowski F; Grubb A; Abrahamson M
Biochemistry; 1998 Mar; 37(12):4071-9. PubMed ID: 9521728
[TBL] [Abstract][Full Text] [Related]
4. Characterization by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases.
Pol E; Olsson SL; Estrada S; Prasthofer TW; Björk I
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):275-82. PubMed ID: 7575465
[TBL] [Abstract][Full Text] [Related]
5. Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.
Lalmanach G; Serveau C; Brillard-Bourdet M; Chagas JR; Mayer R; Juliano L; Gauthier F
J Protein Chem; 1995 Nov; 14(8):645-53. PubMed ID: 8747425
[TBL] [Abstract][Full Text] [Related]
6. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
Estrada S; Nycander M; Hill NJ; Craven CJ; Waltho JP; Björk I
Biochemistry; 1998 May; 37(20):7551-60. PubMed ID: 9585570
[TBL] [Abstract][Full Text] [Related]
7. The affinity and kinetics of inhibition of cysteine proteinases by intact recombinant bovine cystatin C.
Olsson SL; Ek B; Björk I
Biochim Biophys Acta; 1999 Jun; 1432(1):73-81. PubMed ID: 10366730
[TBL] [Abstract][Full Text] [Related]
8. Interaction of cystatin C variants with papain and human cathepsins B, H and L.
Cimerman N; Prebanda MT; Turk B; Popovic T; Dolenc I; Turk V
J Enzyme Inhib; 1999; 14(2):167-74. PubMed ID: 10445041
[TBL] [Abstract][Full Text] [Related]
9. Contributions of individual residues in the N-terminal region of cystatin B (stefin B) to inhibition of cysteine proteinases.
Pol E; Björk I
Biochim Biophys Acta; 2003 Jan; 1645(1):105-12. PubMed ID: 12535617
[TBL] [Abstract][Full Text] [Related]
10. The contribution of N-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain, cathepsin B, and cathepsin L.
Estrada S; Pavlova A; Björk I
Biochemistry; 1999 Jun; 38(22):7339-45. PubMed ID: 10353845
[TBL] [Abstract][Full Text] [Related]
11. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing.
Dahl SW; Halkier T; Lauritzen C; Dolenc I; Pedersen J; Turk V; Turk B
Biochemistry; 2001 Feb; 40(6):1671-8. PubMed ID: 11327826
[TBL] [Abstract][Full Text] [Related]
12. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
Pavlova A; Björk I
Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
[TBL] [Abstract][Full Text] [Related]
13. The importance of the second hairpin loop of cystatin C for proteinase binding. Characterization of the interaction of Trp-106 variants of the inhibitor with cysteine proteinases.
Björk I; Brieditis I; Raub-Segall E; Pol E; Håkansson K; Abrahamson M
Biochemistry; 1996 Aug; 35(33):10720-6. PubMed ID: 8718861
[TBL] [Abstract][Full Text] [Related]
14. Different forms of human cystatin C.
Popović T; Brzin J; Ritonja A; Turk V
Biol Chem Hoppe Seyler; 1990 Jul; 371(7):575-80. PubMed ID: 2222856
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases.
Hall A; Håkansson K; Mason RW; Grubb A; Abrahamson M
J Biol Chem; 1995 Mar; 270(10):5115-21. PubMed ID: 7890620
[TBL] [Abstract][Full Text] [Related]
16. Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition.
Hall A; Dalbøge H; Grubb A; Abrahamson M
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):123-9. PubMed ID: 8471031
[TBL] [Abstract][Full Text] [Related]
17. Probing the functional role of the N-terminal region of cystatins by equilibrium and kinetic studies of the binding of Gly-11 variants of recombinant human cystatin C to target proteinases.
Björk I; Brieditis I; Abrahamson M
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):513-8. PubMed ID: 7887904
[TBL] [Abstract][Full Text] [Related]
18. Human cystatin C. role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase.
Abrahamson M; Mason RW; Hansson H; Buttle DJ; Grubb A; Ohlsson K
Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):621-6. PubMed ID: 1996959
[TBL] [Abstract][Full Text] [Related]
19. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.
Pol E; Björk I
Biochemistry; 1999 Aug; 38(32):10519-26. PubMed ID: 10441148
[TBL] [Abstract][Full Text] [Related]
20. The amino acid sequences, structure comparisons and inhibition kinetics of sheep cathepsin L and sheep stefin B.
Ritonja A; Coetzer TH; Pike RN; Dennison C
Comp Biochem Physiol B Biochem Mol Biol; 1996 Jun; 114(2):193-8. PubMed ID: 8759291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
